Mannkind
MNKD
Mannkind (MNKD) news
Recent news
MannKind Corporation - selling stockholders may offer up to 12,853,470 shares including 2,412,632 warrant shares - SEC filing
AInvest Wire · Aug 21, 2026MannKind Corp shares up 3.4% as FDA approves drug-device combo for fluid buildup
AInvest Wire · Jul 24, 2026MannKind Corp shares up 5.4% premarket after FDA approves co's single-use autoinjector to treat fluid buildup
MannKind Corp. shares rose 5.4% in premarket trading on July 24, 2026, following the U.S. Food and Drug Administration’s (FDA) approval of the company’s single-use autoinjector for the treatment of fluid buildup [1]. The device is intended for patients requiring regular administration of medication…
AInvest Wire · Jul 24, 2026MannKind announces $50 million private placement
AInvest Wire · Jul 24, 2026MannKind reports FDA approval of Furoscix ReadyFlow
AInvest Wire · Jul 24, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
